QIAGEN Opens New Service Solutions Center in Asia
News Feb 22, 2008
QIAGEN has opened a new Service Solutions Center in Singapore for the Asia-Pacific region. The facility completes the Company’s global Service Solution Network by adding a center in the Asia-Pacific region to its existing centers in the United States (Valencia, CA and Germantown, MD), Europe (Hilden, Crawley, Paris) and Japan (Tokyo).
By the end of 2008, QIAGEN’s global customer support network will provide comprehensive solutions-oriented service to customers at any time in any place in the world.
The new center will further increase the Company’s responsiveness to the information and service requirements of customers in research, applied testing, pharma and molecular diagnostics in the entire Asian-Pacific region including Australia.
The facility will serve as a base for QIAGEN employees who will handle customer care and technical service requests in regional languages including Korean, Mandarin, Cantonese, Malay and English.
“QIAGEN not only sets standards in the development of innovative sample and assay technologies, but also for delivering outstanding service solutions”, said Peer M. Schatz, CEO of QIAGEN who hosted the official opening in Singapore.
”With this investment we can better respond to the needs of each and every customer, and we can also extend our services to 24 hours a day, 7 days a week in the near future. It moves us even closer to our customers in all our market segments and helps us extend our global reach and enhance service level in this fast growing region,” Schatz added.
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research. A team of scientists used genome sequencing technology to identify which genes make MRSA susceptible to a previously defined combination of drugs. They identified a number of mutations centered around a protein known as a penicillin-binding protein 2a or PBP2a.